328 related articles for article (PubMed ID: 22500970)
1. Does lithium prevent Alzheimer's disease?
Forlenza OV; de Paula VJ; Machado-Vieira R; Diniz BS; Gattaz WF
Drugs Aging; 2012 May; 29(5):335-42. PubMed ID: 22500970
[TBL] [Abstract][Full Text] [Related]
2. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial.
Forlenza OV; Diniz BS; Radanovic M; Santos FS; Talib LL; Gattaz WF
Br J Psychiatry; 2011 May; 198(5):351-6. PubMed ID: 21525519
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
Forlenza OV; De-Paula VJ; Diniz BS
ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
[TBL] [Abstract][Full Text] [Related]
4. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
[TBL] [Abstract][Full Text] [Related]
5. Lithium, a potential protective drug in Alzheimer's disease.
Engel T; Goñi-Oliver P; Gómez de Barreda E; Lucas JJ; Hernández F; Avila J
Neurodegener Dis; 2008; 5(3-4):247-9. PubMed ID: 18322403
[TBL] [Abstract][Full Text] [Related]
6. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
7. A new avenue for lithium: intervention in traumatic brain injury.
Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM
ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257
[TBL] [Abstract][Full Text] [Related]
8. Reducing the progression of Alzheimer's disease in Down syndrome patients with micro-dose lithium.
Priebe GA; Kanzawa MM
Med Hypotheses; 2020 Apr; 137():109573. PubMed ID: 31986471
[TBL] [Abstract][Full Text] [Related]
9. Lithium may be useful in the prevention of Alzheimer's disease in individuals at risk of presenile familial Alzheimer's disease.
Yeh HL; Tsai SJ
Med Hypotheses; 2008 Dec; 71(6):948-51. PubMed ID: 18760542
[TBL] [Abstract][Full Text] [Related]
10. Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy.
Damri O; Shemesh N; Agam G
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375448
[TBL] [Abstract][Full Text] [Related]
11. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease.
Forlenza OV; Torres CA; Talib LL; de Paula VJ; Joaquim HP; Diniz BS; Gattaz WF
J Psychiatr Res; 2011 Feb; 45(2):220-4. PubMed ID: 20576277
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction in Alzheimer's disease: Therapeutic implications of lithium.
Singulani MP; De Paula VJR; Forlenza OV
Neurosci Lett; 2021 Aug; 760():136078. PubMed ID: 34161823
[TBL] [Abstract][Full Text] [Related]
13. Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium.
Camins A; Verdaguer E; Junyent F; Yeste-Velasco M; Pelegrí C; Vilaplana J; Pallás M
CNS Neurosci Ther; 2009; 15(4):333-44. PubMed ID: 19889130
[TBL] [Abstract][Full Text] [Related]
14. Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease.
Leyhe T; Eschweiler GW; Stransky E; Gasser T; Annas P; Basun H; Laske C
J Alzheimers Dis; 2009; 16(3):649-56. PubMed ID: 19276559
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial.
Forlenza OV; Radanovic M; Talib LL; Gattaz WF
Br J Psychiatry; 2019 Nov; 215(5):668-674. PubMed ID: 30947755
[TBL] [Abstract][Full Text] [Related]
16. Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease.
Mendes CT; Mury FB; de Sá Moreira E; Alberto FL; Forlenza OV; Dias-Neto E; Gattaz WF
Eur Arch Psychiatry Clin Neurosci; 2009 Feb; 259(1):16-22. PubMed ID: 18932008
[TBL] [Abstract][Full Text] [Related]
17. Beneficial synergistic effects of microdose lithium with pyrroloquinoline quinone in an Alzheimer's disease mouse model.
Zhao L; Gong N; Liu M; Pan X; Sang S; Sun X; Yu Z; Fang Q; Zhao N; Fei G; Jin L; Zhong C; Xu T
Neurobiol Aging; 2014 Dec; 35(12):2736-2745. PubMed ID: 25018109
[TBL] [Abstract][Full Text] [Related]
18. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
19. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
[TBL] [Abstract][Full Text] [Related]
20. Influence of lithium treatment on GDNF serum and CSF concentrations in patients with early Alzheimer's disease.
Straten G; Saur R; Laske C; Gasser T; Annas P; Basun H; Leyhe T
Curr Alzheimer Res; 2011 Dec; 8(8):853-9. PubMed ID: 21875410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
